{
    "2021-02-12": [
        [
            {
                "time": "2021-01-12",
                "original_text": "Impact of Covid-19 virus variants on vaccine distribution",
                "features": {
                    "keywords": [
                        "Covid-19",
                        "virus variants",
                        "vaccine distribution"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-02-05",
                "original_text": "Eli Lilly Keeps Piling Up Share Price Gains",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "share price gains"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-03-04",
                "original_text": "Public Health Professor on COVID-19: ‘The big question though is how many people will be willing to get vaccinated’",
                "features": {
                    "keywords": [
                        "public health",
                        "COVID-19",
                        "vaccinated"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-04-10",
                "original_text": "Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "dividend stock",
                        "buy"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-05-01",
                "original_text": "U.S. COVID vaccine program enters new phase as feds deliver jabs directly to drug store chains",
                "features": {
                    "keywords": [
                        "U.S.",
                        "COVID vaccine",
                        "new phase",
                        "drug store chains"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "retail"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-06-15",
                "original_text": "What Is Vaxart Worth Now?",
                "features": {
                    "keywords": [
                        "Vaxart",
                        "worth"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-07-20",
                "original_text": "Can COVID Vaccine Makers Benefit From the Biden Administration?",
                "features": {
                    "keywords": [
                        "COVID Vaccine",
                        "Biden Administration",
                        "makers"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-08-12",
                "original_text": "Pharma Stock Roundup: AZN's Q4 Earnings, FDA Approval for LLY & SNY's Drugs",
                "features": {
                    "keywords": [
                        "Pharma Stock",
                        "AZN",
                        "Q4 Earnings",
                        "FDA Approval",
                        "LLY",
                        "SNY"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-09-05",
                "original_text": "The U.S. is getting plenty of COVID-19 vaccines, but you still won’t have a normal summer",
                "features": {
                    "keywords": [
                        "U.S.",
                        "COVID-19 vaccines",
                        "normal summer"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-10-18",
                "original_text": "The U.S. Will Be Swimming in Covid-19 Vaccines by Midsummer",
                "features": {
                    "keywords": [
                        "U.S.",
                        "Covid-19 Vaccines",
                        "Midsummer"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-11-22",
                "original_text": "How Long Until We Reach Herd Immunity? Expert Timelines Vary",
                "features": {
                    "keywords": [
                        "Herd Immunity",
                        "Expert Timelines"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-12-03",
                "original_text": "Could the U.S. Buying More COVID Vaccines Hurt Johnson & Johnson and Novavax?",
                "features": {
                    "keywords": [
                        "U.S.",
                        "Buying More",
                        "COVID Vaccines",
                        "Johnson & Johnson",
                        "Novavax"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2022-01-10",
                "original_text": "Upstart Entrants and Booster Shots: How the Pandemic Is Changing the Vaccine Industry.",
                "features": {
                    "keywords": [
                        "Upstart Entrants",
                        "Booster Shots",
                        "Pandemic",
                        "Vaccine Industry"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2022-02-15",
                "original_text": "Vaccines, Energy Top South African President’s Priority List",
                "features": {
                    "keywords": [
                        "Vaccines",
                        "Energy",
                        "South African President",
                        "Priority List"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "energy"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            }
        ]
    ]
}